Phases
Phase 1 to Phase 4, interventional and non-interventional.
Experience
Clinical trial experience, Phase 1 to Phase 4.
Experience across complex, multinational trials.
Founder track record
19 years
of clinical trial delivery
Global
start-up experience across the UK, Europe, the Americas, Africa, the Middle East and Asia-Pacific
32 UK sites
activated in 10 weeks
11 years
in study start-up and site activation
Therapeutic areas
Oncology, haemato-oncology, rare diseases, respiratory, inflammation, cardiovascular and paediatrics, with experience in ATMP and gene therapy studies, including GMO trial applications.
Regulatory frameworks
ICH E6(R3), EU CTR 536/2014 and CTIS, MHRA, HRA and Research Ethics Committees, HPRA and NREC-CT submissions in Ireland.
Systems
EDC, eTMF, CTMS, IRT and eCOA platforms.